Home > News > Prof. Gregor Serša: Current developments in clinical application of electrochemotherapy and future directions

Prof. Gregor Serša: Current developments in clinical application of electrochemotherapy and future directions

Date: 20. 2. 2017
Source: Monday physics colloquium
Ponedeljek, 27. februar 2017, ob 16:15 v predavalnici F1, FMF UL, Jadranska 19, Ljubljana
Pred predavanjem vse udeležence vabimo na čaj!

Povzetek:

Current developments in clinical application of electrochemotherapy and future directions 

Prof. Gregor Serša 

Department of Experimental Oncology, Institute of Oncology Ljubljana, Zaloška 2, SI-1000 Ljubljana, Slovenia

 

Electrochemotherapy is now in clinical use for the treatment of different cutaneous metastases and also some primary tumors. It competes with other ablative techniques, having comparable effectiveness, with some advantages over other approaches. The latest developments are in application of electrochemotherapy in head and neck tumors and liver tumors. With advent of the biological therapies and immune checkpoint inhibitors, electrochemotherapy is being tested also in the combined treatment. By the induction of the immunological cell death after electrochemotherapy, it can be considered as in situ vaccination that provides benefit to immunotherapies.